AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
AEON Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.23−0.00 (-0.43%)
Close on Oct 19, 2026
- Market cap
- $11.67M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of AEON Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 30, 2026 | Sep 30, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2026 | Jul 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2026 | Apr 3, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2026 | Jan 21, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 15, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2025 | Jun 11, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Jun 11, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 19, 2025 | Apr 21, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 3, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |